This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Lyme Disease Antigen
Product Overview
BioVenic's Recombinant Lyme Disease Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Lyme disease is a multi-systemic zoonotic illness caused primarily by the spirochete bacterium Borrelia burgdorferi and transmitted via Ixodes ticks. The pathogen dynamically alters its outer membrane proteome to transition between vector and mammalian hosts. Essential targets for diagnostics, therapeutics, and vaccine development include major surface lipoproteins such as Outer Surface Protein A (OspA), which mediates tick midgut attachment, and OspC, Decorin-binding protein A (DbpA), and VlsE, which are critical for mammalian tissue dissemination and immune evasion.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.